Search

Your search keyword '"Kuppermann BD"' showing total 260 results

Search Constraints

Start Over You searched for: Author "Kuppermann BD" Remove constraint Author: "Kuppermann BD"
260 results on '"Kuppermann BD"'

Search Results

1. Biosimilars in ophthalmology: “Is there a big change on the horizon?&rdquo

3. Diabetic Retinopathy and VEGF

4. Corticosteroids and Anti-Complement Therapy in Retinal Diseases

5. ONSET AND DURATION OF VISUAL ACUITY IMPROVEMENT AFTER DEXAMETHASONE INTRAVITREAL IMPLANT IN EYES WITH MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION

6. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study

8. Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion

9. Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion

13. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study

14. Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).

15. Subfoveal neurosensory detachment flattening and observe (SNF-Ob) approach for the management of Ci-DMO - a multicentric study.

16. RWC Update: Two Dropped IOLs, One Rigid IOL in Sulcus and Choroidal Detachment; Is AI Ready for the Clinical Retina Practice?; Pseudopapilledema From Leukemic Optic Nerve Infiltration.

17. Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases.

19. Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs.

20. Global experience of faricimab in clinical settings - a review.

22. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4 + and CD8 + memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients.

23. A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model.

25. Cross-protection induced by highly conserved human B, CD4 + , and CD8 + T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern.

27. Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases.

28. The role of mitochondrial genes on nuclear gene expression in neovascular age related macular degeneration: analysis of nuclear VEGF gene expression after ranibizumab treatment in cytoplasmic hybrid retinal pigment epithelial cell lines correlated with clinical evolution.

29. Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey).

31. Preparing for the next decade of anti-VEGF biosimilars for retinal diseases: a focus on South Asia.

32. Potential Therapeutic Functions of PU-91 and Quercetin in Personalized Cybrids Derived from Patients with Age-Related Macular Degeneration, Keratoconus, and Glaucoma.

33. Cross-Protection Induced by Highly Conserved Human B, CD4 +, and CD8 + T Cell Epitopes-Based Coronavirus Vaccine Against Severe Infection, Disease, and Death Caused by Multiple SARS-CoV-2 Variants of Concern.

34. Stability Determination of Intact Humanin-G with Characterizations of Oxidation and Dimerization Patterns.

35. Vitreal Concentrations of Vascular Endothelial Growth Factor in Patients with Rhegmatogenous Retinal Detachment.

42. Differential Epigenetic Status and Responses to Stressors between Retinal Cybrids Cells with African versus European Mitochondrial DNA: Insights into Disease Susceptibilities.

43. Differential modulation of cancer-related genes by mitochondrial DNA haplogroups and the STING DNA sensing system.

44. Color Vision and Microperimetry Changes in Nonexudative Age-Related Macular Degeneration After Risuteganib Treatment: Exploratory Endpoints in a Multicenter Phase 2a Double-Masked, Randomized, Sham-Controlled, Crossover Clinical Trial.

48. Supplemental nutrition for retinal health: Evidence based analysis of commercial preparations in India.

49. Impacts of Bacteriostatic and Bactericidal Antibiotics on the Mitochondria of the Age-Related Macular Degeneration Cybrid Cell Lines.

50. Ranibizumab Biosimilar (Razumab) vs Innovator Ranibizumab (Lucentis) in neovascular age-related macular degeneration (n-AMD)- efficacy and safety (BIRA study).

Catalog

Books, media, physical & digital resources